Search Tag: AOP Orphan Pharmaceuticals GmbH
2024 20 Feb
Individualized therapies and the integration of the patient's perspective are becoming increasingly important. February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more
2023 12 Dec
The entire EU pharmaceutical legislation is currently being negotiated. Among the regulations to be redefined are those concerning rare diseases. Experts fear that the planned changes – in particular by shortening protection periods – will lower the incentive for companies to conduct research in the field of rare diseases. This would reduce the availability...Read more